NL-OMON32720撤回3 期
Reduction of Bone Morbidity using Oral Bisphosphonate in Fibrous Dysplasia of Bone - PROFIDYS
适应症
试验速览
- 阶段
- 3 期
- 状态
- 撤回
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Study I: Patients with fibrous dysplasia with painful bone lesions of intensity higher than 3 on a visual analog scale from 0 to 10.
- •Study II: Patients with fibrous dysplasia with at least on osteolytic lesion and no current bone pain.
排除标准
- •patients younger than 18 years (for the Dutch protocol)
- •patients with other bone diseases or receiving treatments likely to affect bone metabolism
- •renal insufficiency (CCR <25 ml/min)
- •liver disease
研究者
相似试验
进行中（未招募）
不适用
Reduction of Bone Morbidity Using an Oral Bisphosphonate in Fibrous Dysplasia of Bone - PROFIDYSFibrous Dysplasia of Bone, MedDRA 8.0, 10016664EUCTR2006-003549-18-NLZonMw156
进行中（未招募）
1 期
REDUCTION OF BONE MORBIDITY USING AN ORAL BISPHOSPHONATE IN FIBROUS DYSPLASIA OF BONE (PROFIDYS Trial) - PROFIDYS TrialEUCTR2006-003549-18-BECliniques Universitaires SAINT-LUC156
已完成
不适用
Examination of utility of bisphosphonate to osteoporosis by ovarian insufficiency after gynecologic cancer treatmentOsteoporosis after gynecologic cancer treatmentJPRN-UMIN000005665Gifu University50
已完成
不适用
Effect of treatment with an oral bisphosphonate on markers of bone formation and bone resorption in adults with alkpatonuriaISRCTN12672997niversity Medical Centre Utrecht (UMCU) (The Netherlands)6
已完成
不适用
Bisphosphonates Effects On Alveolar Bone Among Osteoporotic WomenOsteoporosisNCT02115490Damascus University60